NEW Our free Dividend Tracker is live — see what your stocks pay you
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

LeMaitre Vascular, Inc. LMAT | NASDAQ

$84.21 $1.59 | 1.92%
TREND SIGNAL:Signal available — unlock to view |2026-08-05
Add to favoritesFavorite

Company Overview:

Market Cap: $1.89B
Trailing PE: 29.5x
FWD PE *: 27.6x
Payout Ratio (TTM): 31.2%
52-Week Range: $78.22 - $118.01

* Forward PE is based on street estimates.

7.3 Year LMAT Performance Metrics:

Total Return (with DRIP): 226.1% (17.58% CAGR)
Total Return (no DRIP): 218.5% (17.20% CAGR)
Share Price: 204.1% (16.46% CAGR)
Yield on Cost (with DRIP): 3.87%
Total Invested: $10,000
Total Value (with DRIP): $32,614
Total Return $ (with DRIP): $22,614
Dividend Increase: 194.1% (16.66% CAGR)
Dividend Yield (FWD): 1.19% ($1.00)
LMAT 7.3-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
LMAT Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
LMAT Price CAGR:1Y: -3.50%2Y: -3.93%5Y: 9.46%10Y: 16.41%
LMAT Dividend Charts
LMAT - Dividends
LMAT Dividend CAGR:1Y: 25.00%2Y: 25.00%5Y: 17.84%10Y: 18.71%
LMAT - Dividend Payout Ratio
LMAT Dividend Payout Ratio CAGR:1Y: 2.20%2Y: 5.04%5Y: 4.18%10Y: -6.21%
LMAT - Dividend to Free Cash Flow Ratio
LMAT Dividend to FCF Ratio CAGR:1Y: 75.53%2Y: -4.99%5Y: 9.42%10Y: 1.43%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

LMAT Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

LMAT - Revenue
LMAT Revenue CAGR:1Y: 9.57%2Y: 12.26%5Y: 11.59%10Y: 12.14%
LMAT - Earnings Per Share (EPS)
LMAT EPS CAGR:1Y: 23.33%2Y: 19.29%5Y: 13.09%10Y: 18.12%
LMAT - Net Income
🔓 See the full chart40% off right now · 7-day free trial
LMAT Net Income CAGR:1Y: 23.74%2Y: 20.07%5Y: 15.49%10Y: 20.70%
LMAT - EBITDA
🔓 See the full chart40% off right now · 7-day free trial
LMAT EBITDA CAGR:1Y: 18.79%2Y: 24.90%5Y: 18.68%10Y: 21.33%
LMAT - Free Cash Flow
🔓 See the full chart40% off right now · 7-day free trial
LMAT Free Cash Flow CAGR:1Y: -27.95%2Y: 32.75%5Y: 9.96%10Y: 11.61%
LMAT - Free Cash Flow / Share
🔓 See the full chart40% off right now · 7-day free trial
LMAT Free Cash Flow / Share CAGR:1Y: -28.72%2Y: 31.58%5Y: 7.70%10Y: 9.22%
LMAT - Operating Income
🔓 See the full chart40% off right now · 7-day free trial
LMAT Operating Income CAGR:1Y: 26.37%2Y: 19.10%5Y: 12.93%10Y: 18.35%
LMAT - Gross Profit
🔓 See the full chart40% off right now · 7-day free trial
LMAT Gross Profit CAGR:1Y: 12.87%2Y: 14.88%5Y: 0.00%10Y: 0.00%
LMAT - Shares Outstanding
🔓 See the full chart40% off right now · 7-day free trial
LMAT Shares Outstanding CAGR:1Y: 7.16%2Y: 3.90%5Y: 3.20%10Y: 2.60%
LMAT - Share Buybacks
🔓 See the full chart40% off right now · 7-day free trial
LMAT Share Buybacks CAGR:1Y: -81.36%2Y: 300.00%5Y: 0.00%10Y: 49.56%
LMAT - Stock-Based Comp
🔓 See the full chart40% off right now · 7-day free trial
LMAT Stock-Based Comp CAGR:1Y: -0.46%2Y: 9.66%5Y: 17.36%10Y: 19.28%
LMAT - Expenses
🔓 See the full chart40% off right now · 7-day free trial
LMAT Expenses CAGR:1Y: 72.35%2Y: 10.98%5Y: 10.52%10Y: 15.57%
LMAT - Revenue vs Net Income
🔓 See the full chart40% off right now · 7-day free trial
LMAT - EPS vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
LMAT - EPS vs PE Ratio
🔓 See the full chart40% off right now · 7-day free trial
LMAT - FCF vs FCF / Share
🔓 See the full chart40% off right now · 7-day free trial
LMAT - FCF vs Stock Based Comp
🔓 See the full chart40% off right now · 7-day free trial
LMAT - Cash & Debt
🔓 See the full chart40% off right now · 7-day free trial
LMAT - Revenue by Segment
🔓 See the full chart40% off right now · 7-day free trial
LMAT Revenue CAGR:1Y: 9.57%2Y: 12.26%5Y: 11.59%10Y: 12.14%
LMAT - Revenue by Region
🔓 See the full chart40% off right now · 7-day free trial
LMAT Revenue CAGR:1Y: 9.57%2Y: 12.26%5Y: 11.59%10Y: 12.14%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

LMAT - REVENUE: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
LMAT Actual Revenue CAGR:1Y: 9.57%2Y: 12.26%5Y: 11.59%10Y: 12.14%
LMAT - EPS: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
LMAT Actual EPS CAGR:1Y: 23.33%2Y: 19.29%5Y: 13.09%10Y: 18.12%
LMAT - NET INCOME: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
LMAT Actual Net Income CAGR:1Y: 23.74%2Y: 20.07%5Y: 15.49%10Y: 20.70%
LMAT - EBITDA: Actual + Estimates
🔓 See the full chart40% off right now · 7-day free trial
LMAT Actual EBITDA CAGR:1Y: 18.79%2Y: 24.90%5Y: 18.68%10Y: 21.33%

Ratios, Profit Margins & Return on Capital:

LMAT - Net Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
LMAT Net Profit Margin CAGR:1Y: 12.91%2Y: 6.96%5Y: 3.48%10Y: 7.64%
LMAT - Gross Profit Margin
🔓 See the full chart40% off right now · 7-day free trial
LMAT Gross Profit Margin CAGR:1Y: 3.01%2Y: 2.33%5Y: 1.85%10Y: 0.50%
LMAT - Price to Earnings
🔓 See the full chart40% off right now · 7-day free trial
LMAT Price to Earnings CAGR:1Y: -6.02%2Y: -8.55%5Y: -3.33%10Y: 2.38%
LMAT - Price To Sales Ratio
🔓 See the full chart40% off right now · 7-day free trial
LMAT Price To Sales Ratio CAGR:1Y: 6.59%2Y: -1.92%5Y: 0.16%10Y: 10.26%
LMAT - Return on Capital Employed
🔓 See the full chart40% off right now · 7-day free trial
LMAT Return on Capital Employed CAGR:1Y: 13.16%2Y: -11.43%5Y: -7.51%10Y: -2.78%
LMAT - Return on Invested Capital
🔓 See the full chart40% off right now · 7-day free trial
LMAT Return on Invested Capital CAGR:1Y: 13.98%2Y: -10.67%5Y: -8.19%10Y: -1.90%

Compare stocks side-by-side

LMAT Dividends Info:

Annual Dividend: $1
Forward Yield: 1.19%
Ex-Dividend Date: 2026-08-20
Lifetime Dividends / Share: $5.69

LMAT Dividend History: Dates, Payments & Yield list

Below is a schedule of all LMAT dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date Payment Date Amount Yield Forward Yield Price on Ex-Date
08/20/202608/24/2026$0.2501.21%1.25%$79.96
05/21/202605/25/2026$0.2501%1.07%$93.56
03/12/202603/16/2026$0.2500.94%0.9%$110.75
11/20/202511/24/2025$0.2000.95%0.95%$84.28
08/21/202508/25/2025$0.2000.83%0.82%$97.60
05/15/202505/19/2025$0.2000.96%0.93%$85.96
03/13/202503/17/2025$0.2001.02%0.94%$85.11
11/21/202411/25/2024$0.1600.6%0.6%$107.09
08/15/202408/19/2024$0.1600.77%0.75%$85.53
05/15/202405/17/2024$0.1600.82%0.82%$78.45
03/13/202403/15/2024$0.1600.96%0.96%$66.84
11/15/202311/17/2023$0.1401.07%1.05%$53.11
08/16/202308/18/2023$0.1401.01%1.02%$55.14
05/16/202305/18/2023$0.1400.87%0.89%$63.15
03/08/202303/10/2023$0.1401.14%1.17%$47.97
11/16/202212/01/2022$0.1251.1%1.05%$47.42
08/24/202209/08/2022$0.1250.99%0.99%$50.74
05/16/202206/02/2022$0.1251.15%1.09%$46.00
03/07/202203/24/2022$0.1251.08%1.12%$44.79
11/18/202112/02/2021$0.1100.85%0.91%$48.53
08/25/202109/09/2021$0.1100.81%0.75%$59.01
05/18/202106/03/2021$0.1100.91%0.86%$51.40
03/08/202103/25/2021$0.1100.94%0.94%$46.79
11/18/202012/03/2020$0.0951%1.04%$36.57
08/26/202009/10/2020$0.0951.21%1.21%$31.50
05/19/202006/04/2020$0.0951.53%1.41%$26.95
03/02/202003/19/2020$0.0951.31%1.6%$23.68
11/19/201912/05/2019$0.0850.99%0.95%$35.88
08/20/201909/05/2019$0.0851.09%1.07%$31.78
05/21/201906/06/2019$0.0850%1.23%$27.69
03/21/201904/05/2019$0.0850%1.23%$27.69
11/19/201812/06/2018$0.0700%1.01%$27.69
08/21/201809/06/2018$0.0700%1.01%$27.69
05/21/201806/07/2018$0.0700%1.01%$27.69
03/21/201804/05/2018$0.0700%1.01%$27.69
11/21/201712/07/2017$0.0550%0.79%$27.69
08/21/201709/07/2017$0.0550%0.79%$27.69
05/22/201706/08/2017$0.0550%0.79%$27.69
03/20/201704/06/2017$0.0550%0.79%$27.69
11/17/201612/05/2016$0.0450%0.65%$27.69
08/18/201609/06/2016$0.0450%0.65%$27.69
05/23/201606/08/2016$0.0450%0.65%$27.69
03/17/201604/04/2016$0.0450%0.65%$27.69
11/18/201512/04/2015$0.0400%0.58%$27.69
08/18/201509/03/2015$0.0400%0.58%$27.69
05/20/201506/05/2015$0.0400%0.58%$27.69
03/18/201504/03/2015$0.0400%0.58%$27.69
11/18/201412/04/2014$0.0350%0.51%$27.69
08/19/201409/04/2014$0.0350%0.51%$27.69
05/20/201406/05/2014$0.0350%0.51%$27.69
03/18/201404/03/2014$0.0350%0.51%$27.69
11/18/201312/04/2013$0.0300%0.43%$27.69
08/19/201309/04/2013$0.0300%0.43%$27.69
05/20/201306/05/2013$0.0300%0.43%$27.69
03/18/201304/03/2013$0.0300%0.43%$27.69
11/16/201212/04/2012$0.0250%0.36%$27.69
08/15/201209/04/2012$0.0250%0.36%$27.69
05/16/201206/04/2012$0.0250%0.36%$27.69
03/16/201204/03/2012$0.0250%0.36%$27.69
11/21/201112/06/2011$0.0200%0.29%$27.69
08/17/201109/06/2011$0.0200%0.29%$27.69
05/18/201106/06/2011$0.0200%0.29%$27.69
03/18/201104/05/2011$0.0200%0.29%$27.69

Projected Future Returns & Dividends for LMAT

Based on past 7.3-year performance, here are LMAT growth metrics:

Share price CAGR of +16.46%
Dividend CAGR of +18.78%

Using LMAT CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

LMAT (DRIP)LMAT - No DRIP
Current Price$84.21$84.21
Start Shares118.75118.75
Start Value$10,000$10,000
  
After 10 years:
Final Share Count135.21118.75
Dividends Payment$1.40$1.40
Annual Dividends$756$664
Yield on cost7.56%6.64%
Share Price$386.42$386.42
Total Dividends$3,143$2,903
Final Value$52,248$48,791

Estimated Future Value + Dividends - LMAT

NOTE: Above numbers are our estimate based on LMAT's Dividend and Price CAGR over past 7.3 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount

Company Info

LeMaitre Vascular, Inc. (LMAT) had its IPO on 2006-10-19, and is traded on NASDAQ stock exchange.

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

LMAT website: https://www.lemaitre.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
Combined 55% Lifetime Discount
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
Combined 55% Lifetime Discount
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
Combined 55% Lifetime Discount
Loading signals…

DCF Model — LMAT

Value from:
Pay up to today
—
vs current price $84.21
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →